X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Sports Nutrition Leader Iovate Health Sciences Announces Strategic Investment by Xiwang Foodstuffs to Accelerate Growth in China

Content Team by Content Team
1st October 2017
in Health & Nutrition

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Iovate Health Sciences International, Inc. announced that it has reached a definitive agreement to receive a majority equity investment from Shenzhen-listed Xiwang Foodstuffs Co., Ltd. (“Xiwang Food”). The transaction will accelerate Iovate’s growth in China and provide its brands with significant product expansion globally.

The Iovate Executive Team states, “Over the last 20 years, our teams at Iovate have built a business that has given our brands an industry-leading position in North America and throughout the world. Through this strategic partnership with well-established consumer products leader Xiwang, we now have the unique opportunity to accelerate our international growth, particularly in the China market. MuscleTech is already gaining significant momentum in China, and this partnership solidifies that position into what we believe will deliver significant growth in a reasonably short period of time.”

Iovate will maintain its North American headquarters in Oakville, Canada. All Executives and Senior Leaders, as well as its 330 existing employees, will remain in place to take the business to the next level of growth. At the close of this transaction, Iovate’s CEO will maintain a significant ownership stake in Iovate and will remain on as CEO.

The proposed transaction is subject to the satisfaction of closing conditions, including customary regulatory approvals in Canada and China. The transaction is expected to close later in the calendar year.

Houlihan Lokey is serving as exclusive financial advisor to Iovate and assisting in structuring and negotiating the transaction. Goodmans LLP is serving as the legal advisor to Iovate.

Founded in 1995 and based in Oakville, Canada, Iovate is a dynamic, leading-edge nutritional company that delivers some of the highest quality, most innovative and effective active nutrition products in the world. With brand innovations like MuscleTech, Six Star Pro Nutrition, Purely Inspired and Hydroxycut, the company is committed to being the number one active nutrition and weight management supplement company in the world. Iovate distributes across all major channels of distribution, including food, drug, mass and club, health food stores and online, as well as in more than 130 countries worldwide. Iovate products are available nationwide at GNC, The Vitamin Shoppe, Bodybuilding.com, WalMart, Target, Walgreen’s, Sam’s Club, Amazon.com and other fine retailers.

Founded in 2007 and based in Shandong Province, China, Xiwang Food is the leading Chinese player in healthy consumable oils such as corn oil and flaxseed oil. Xiwang Food has a vast sales and distribution network, selling its products in more than 85,000 mass merchandise stores and over 2,000 drug stores in China. Xiwang Food is listed on the Shenzhen Stock Exchange (SZ000639) since 2011 and currently has more than 5,000 employees. Xiwang Food is a subsidiary of Xiwang Group Company Limited (“Xiwang Group”), a large industrial enterprise company that also maintains investments in specialty steel, real estate, energy and beverages, among other sectors. Xiwang Group is ranked among the 500 largest companies in China with consolidated revenue in excess of $5 billion.

Previous Post

Recipharm equips Lisbon facility for US and European serialisation

Next Post

Bharat Biotech’s new typhoid vaccine shows high efficacy in study

Related Posts

Health & Nutrition

Vitafoods India 2025 Ignites Powerful Knowledge Exchange, Elevating the Future of Nutraceuticals

7th February 2025
Danone Ltd invests €100m in specialized nutrition in China
Health & Nutrition

Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform

13th February 2024
Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer
Health & Nutrition

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

13th January 2024
Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health
Health & Nutrition

Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

13th January 2024
Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition
Health & Nutrition

Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

13th January 2024
Nestle unveils science-backed innovation for early-life nutrition
Health & Nutrition

Nestle unveils science-backed innovation for early-life nutrition

13th January 2024
Next Post

Zimmer Biomet introduces Avenue T TLIF Cage with integrated VerteBRIDGE plating in US market

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In